To help protect Saskatchewan residents from emerging disease threats, Hospitals of Regina Foundation has invested $150,000 to help establish Canada’s Centre for Pandemic Research at USask's Vaccine and Infectious Disease Organization.
One of the newest scientists at the University of Saskatchewan’s Vaccine and Infectious Disease Organization has published new research on potential lasting effects of COVID-19.
The Vaccine and Infectious Disease Organization at the University of Saskatchewan announced positive interim results from their Phase 1 clinical trial for COVAC-2, VIDO’s COVID-19 subunit vaccine candidate.